ResMed (RMD) PT Raised to $76 at Barclays

January 23, 2018 5:18 AM EST
Get Alerts RMD Hot Sheet
Price: $224.59 -3.26%

Rating Summary:
    12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 15 | Down: 21 | New: 16
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Barclays raised its price target on ResMed (NYSE: RMD) to $76.00 (from $70.00) while maintaining a Underweight rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities